Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > I'm still trying to figure out
View:
Post by YukonJezza on Apr 23, 2021 10:51am

I'm still trying to figure out

I'm still trying to figure out which insider Mugsy is. Is he Dan or Wallace. ? You know Dan had 8 years to alagamate. I'm sure things would have been cheaper if they did this at the beginning
Comment by MrMugsy on Apr 23, 2021 11:19am
Obviously you're kidding as neither Dan or John would participate here in this manner. There was no need or desire to amalgamate in the past - this separation was actually a perfect perservation tool to ensure against an easy hostile takeover. You can play armchair CEO or CSO and second-guess developments but none of it matters.  Just enjoy the ride into 2022 - if you have shares. If ...more  
Comment by Stoxxhp on Apr 23, 2021 11:26am
This post has been removed in accordance with Community Policy
Comment by Pragmatist on Apr 23, 2021 12:26pm
Amalgamation would likely be necessary if Pfizer or another pharma is seeking more than a standard licensing deal.   Dan recently confirmed by email what he said during BioPub, that is, Antibe (and not Holdings) owns the IP associated with the new molecules activity.   This might explain in part why there is a need to unify the control/ownership of the IP at this time when ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities